Study points to potential new therapies for hard-to-treat lung cancers
Medical Xpress
March 5, 2026
Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) support the potential of new therapies that could improve clinical outcomes for patients with squamous and adenocarcinoma non-small cell lung cancers (NSCLC) that don't respond to immunotherapy. The study is published in the journal Science Translational Medicine.
Verticals
healthmedical
Originally published on Medical Xpress on 3/5/2026